September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.
The Wellness Gap: Dr. Erhunmwunsee on Ethnic Disparities in Lung Cancer
November 30, 2016 | Samantha Bonar
Despite the fact that overall rates of lung cancer have been declining in the United States for some time, disparities in incidence and outcome along racial lines still exist, particularly among the African American population. City of Hope's thoracic surgeon, Loretta Erhunmwunsee, M.D., discusses research findings.
City of Hope's Ravi Salgia, M.D., receives award for treatment, research on lung cancer
November 16, 2016 | Letisia Marquez
City of Hope’s Ravi Salgia, M.D., Ph.D., chair of the Department of Medical Oncology and Therapeutics Research, has received yet another accolade that recognizes his decades-long dedication to treating lung cancer patients and researching new therapies.
Lung cancer 2016: New drugs, more screening point to a brighter new year
December 23, 2015 | Veronique de Turenne
After years of modest gains in the field of lung cancer, the leading cause of cancer-related deaths throughout the world, doctors and researchers say significant advances in treatment and screening practices point to very good news in 2016.
4 facts women should know about lung cancer (w/podcast)
December 9, 2015 | Denise Heady
At City of Hope, physicians and researchers are working tirelessly to find new and better treatments for lung cancer, especially in the most advanced and difficult-to-treat cases. Here, Loretta Erhunmwunsee, M.D., assistant professor in the Division of Thoracic Surgery, at City of Hope, presents a fuller picture of lung cancer.
If you’re at risk, annual lung cancer screenings could save your life
November 4, 2015 | Veronique de Turenne
When it comes to life-saving messages, it doesn’t get much simpler than this: if you’re a smoker, a former smoker, or possess these risk factors, an annual lung cancer screening could be the difference between life and death.
ASCO 2015: Drug combination promising for some lung cancer patients
May 29, 2015 | Nicole Levine
Lung cancer patients in need of improved treatment options may soon get good news, with a new combination therapy showing promise where other treatments have failed. City of Hope researchers share findings on a promising combination treatment for lung cancer.
How is environment linked to cancer? Study helps explain
September 23, 2014 | Nicole White
The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer.
AACR report: Now is the time to invest in cancer research
September 16, 2014 | Nicole White
Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life.
ASCO 2014: New drug may overcome lung cancer's chemotherapy resistance
May 21, 2014 | Hiu Chung So
For lung cancer patients whose tumors are resistant to a class of chemotherapy called tyrosine kinase inhibitors (TKI), a drug called cabozantinib may be able to undo that resistance, according to a new City of Hope study.